Advertisement

World Journal of Surgery

, Volume 43, Issue 3, pp 870–877 | Cite as

Intraoperative Blood Loss is Associated with Shortened Postoperative Survival of Patients with Stage II/III Gastric Cancer: Analysis of a Multi-institutional Dataset

  • Yuki Ito
  • Mitsuro KandaEmail author
  • Seiji Ito
  • Yoshinari Mochizuki
  • Hitoshi Teramoto
  • Kiyoshi Ishigure
  • Toshifumi Murai
  • Takahiro Asada
  • Akiharu Ishiyama
  • Hidenobu Matsushita
  • Chie Tanaka
  • Daisuke Kobayashi
  • Michitaka Fujiwara
  • Kenta Murotani
  • Yasuhiro Kodera
Original Scientific Report (including Papers Presented at Surgical Conferences)

Abstract

Background

The influence of intraoperative blood loss (IBL) on postoperative long-term outcomes of patients with gastric cancer is controversial. Here, we used a large multicenter dataset from nine institutes to evaluate the prognostic impact of IBL on patients with stage II/III gastric cancer.

Methods

The study analyzed 1013 patients with stage II/III gastric cancer who underwent gastrectomy without preoperative treatment and intraoperative transfusion. Patients were equally divided into learning and validation cohorts using a table of random numbers. The optimal cutoff value of IBL to predict recurrence was determined using the learning cohort, and the prognostic significance of the proposed cutoff was validated using the second cohort.

Results

The optimal cutoff value of IBL determined with the learning cohort using the receiver operating characteristic curve analysis was 330 ml. In the validation cohort, IBL > 330 ml was significantly associated with high body mass index, total gastrectomy, and postoperative complications, but not disease stage and the frequency of adjuvant chemotherapy. The disease-free and disease-specific survival rates of patients in the IBL > 330 ml (IBL-high) group were significantly shorter compared with those in the IBL ≤ 330 ml group. IBL-high was identified as an independent prognostic factor of disease recurrence (hazard ratio 1.45, 95% confidence interval 1.01–2.09, P = 0.0420). The hazard ratio of the IBL-high group was greater in the surgery-alone subgroup compared with that of the postoperative adjuvant-chemotherapy subgroup.

Conclusions

Our analysis of a multicenter dataset indicates that IBL adversely influenced long-term outcomes of patients with stage II/III gastric cancer.

Notes

Acknowledgements

We thank Edanz Group (www.edanzediting.com/ac) for editing a draft of this manuscript.

Compliance with ethical standards

Conflict of interest

The authors do not have any conflicts of interest or financial or material support to disclose.

Ethical standard

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.

References

  1. 1.
    Van Cutsem E, Sagaert X, Topal B et al (2016) Gastric cancer. Lancet 388:2654–2664CrossRefGoogle Scholar
  2. 2.
    Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386CrossRefGoogle Scholar
  3. 3.
    Shen L, Shan YS, Hu HM et al (2013) Management of gastric cancer in Asia: resource-stratified guidelines. Lancet Oncol 14:e535–e547CrossRefGoogle Scholar
  4. 4.
    Kanda M, Tanaka C, Kobayashi D et al (2017) Proposal of the Coagulation Score as a predictor for short-term and long-term outcomes of patients with resectable gastric cancer. Ann Surg Oncol 24:502–509CrossRefGoogle Scholar
  5. 5.
    Shum H, Rajdev L (2014) Multimodality management of resectable gastric cancer: a review. World J Gastrointest Oncol 6:393–402CrossRefGoogle Scholar
  6. 6.
    Nagai S, Fujii T, Kodera Y et al (2011) Impact of operative blood loss on survival in invasive ductal adenocarcinoma of the pancreas. Pancreas 40:3–9CrossRefGoogle Scholar
  7. 7.
    Kamei T, Kitayama J, Yamashita H et al (2009) Intraoperative blood loss is a critical risk factor for peritoneal recurrence after curative resection of advanced gastric cancer. World J Surg 33:1240–1246.  https://doi.org/10.1007/s00268-009-9979-4 CrossRefGoogle Scholar
  8. 8.
    Morner ME, Gunnarsson U, Jestin P et al (2012) The importance of blood loss during colon cancer surgery for long-term survival: an epidemiological study based on a population based register. Ann Surg 255:1126–1128CrossRefGoogle Scholar
  9. 9.
    Mizuno A, Kanda M, Kobayashi D et al (2016) Adverse effects of intraoperative blood loss on long-term outcomes after curative gastrectomy of patients with stage II/III gastric cancer. Dig Surg 33:121–128CrossRefGoogle Scholar
  10. 10.
    Japanese Gastric Cancer Association (2017) Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer 20:1–19CrossRefGoogle Scholar
  11. 11.
    Liu JY, Peng CW, Yang XJ et al (2018) The prognosis role of AJCC/UICC 8(th) edition staging system in gastric cancer, a retrospective analysis. Am J Transl Res 10:292–303Google Scholar
  12. 12.
    Kanda M, Kobayashi D, Tanaka C et al (2016) Adverse prognostic impact of perioperative allogeneic transfusion on patients with stage II/III gastric cancer. Gastric Cancer 19:255–263CrossRefGoogle Scholar
  13. 13.
    Kanda M, Tanaka C, Kobayashi D et al (2018) Preoperative albumin–bilirubin grade predicts recurrences after radical gastrectomy in patients with pT2-4 gastric cancer. World J Surg 42:773–781.  https://doi.org/10.1007/s00268-017-4234-x CrossRefGoogle Scholar
  14. 14.
    Kanda M, Kodera Y, Sakamoto J (2015) Updated evidence on adjuvant treatments for gastric cancer. Expert Rev Gastroenterol Hepatol 9:1549–1560CrossRefGoogle Scholar
  15. 15.
    Sasako M, Sakuramoto S, Katai H et al (2011) Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol 29:4387–4393CrossRefGoogle Scholar
  16. 16.
    Kanda M, Murotani K, Kobayashi D et al (2015) Postoperative adjuvant chemotherapy with S-1 alters recurrence patterns and prognostic factors among patients with stage II/III gastric cancer: a propensity score matching analysis. Surgery 158:1573–1580CrossRefGoogle Scholar
  17. 17.
    Miki Y, Tokunaga M, Tanizawa Y et al (2014) Perioperative risk assessment for gastrectomy by surgical apgar score. Ann Surg Oncol 21:2601–2607CrossRefGoogle Scholar
  18. 18.
    Squires MH III, Kooby DA, Poultsides GA et al (2015) Effect of perioperative transfusion on recurrence and survival after gastric cancer resection: a 7-institution analysis of 765 patients from the US gastric cancer collaborative. J Am Coll Surg 221:767–777CrossRefGoogle Scholar
  19. 19.
    Pacelli F, Rosa F, Marrelli D et al (2011) Do perioperative blood transfusions influence prognosis of gastric cancer patients? Analysis of 927 patients and interactions with splenectomy. Ann Surg Oncol 18:1615–1623CrossRefGoogle Scholar
  20. 20.
    Yamashita K, Sakuramoto S, Kikuchi S et al (2007) Transfusion alert for patients with curable cancer. World J Surg 31:2315–2322.  https://doi.org/10.1007/s00268-007-9237-6 CrossRefGoogle Scholar
  21. 21.
    Baumgartner JM, Silliman CC, Moore EE et al (2009) Stored red blood cell transfusion induces regulatory T cells. J Am Coll Surg 208:110–119CrossRefGoogle Scholar
  22. 22.
    Zhou HY, Yi W, Wang J et al (2014) Association of perioperative allogeneic blood transfusions and prognosis of patients with gastric cancer after curative gastrectomy. Am J Surg 208:80-87CrossRefGoogle Scholar
  23. 23.
    Dhar DK, Kubota H, Tachibana M et al (2000) Long-term survival of transmural advanced gastric carcinoma following curative resection: multivariate analysis of prognostic factors. World J Surg 24:588–593.  https://doi.org/10.1007/s002689910099 discussion 93–4 CrossRefGoogle Scholar
  24. 24.
    Hyung WJ, Noh SH, Shin DW et al (2002) Adverse effects of perioperative transfusion on patients with stage III and IV gastric cancer. Ann Surg Oncol 9:5–12CrossRefGoogle Scholar
  25. 25.
    Bruns CJ, Schafer H, Wolfgarten B et al (1996) Effect of intraoperative blood loss on the function of natural killer cells in tumors of the upper gastrointestinal tract. Langenbecks Arch Chir Suppl Kongressbd 113:146–149Google Scholar

Copyright information

© Société Internationale de Chirurgie 2018

Authors and Affiliations

  • Yuki Ito
    • 1
  • Mitsuro Kanda
    • 2
    Email author
  • Seiji Ito
    • 3
  • Yoshinari Mochizuki
    • 4
  • Hitoshi Teramoto
    • 5
  • Kiyoshi Ishigure
    • 6
  • Toshifumi Murai
    • 7
  • Takahiro Asada
    • 1
  • Akiharu Ishiyama
    • 8
  • Hidenobu Matsushita
    • 9
  • Chie Tanaka
    • 2
  • Daisuke Kobayashi
    • 2
  • Michitaka Fujiwara
    • 2
  • Kenta Murotani
    • 10
  • Yasuhiro Kodera
    • 2
  1. 1.Department of SurgeryGifu Prefectural Tajimi HospitalTajimiJapan
  2. 2.Department of Gastroenterological Surgery (Surgery II)Nagoya University Graduate School of MedicineNagoyaJapan
  3. 3.Department of Gastroenterological SurgeryAichi Cancer CenterNagoyaJapan
  4. 4.Department of SurgeryKomaki Municipal HospitalKomakiJapan
  5. 5.Department of SurgeryYokkaichi Municipal HospitalYokkaichiJapan
  6. 6.Department of SurgeryKonan Kosei HospitalKonanJapan
  7. 7.Department of SurgeryIchinomiya Municipal HospitalIchinomiyaJapan
  8. 8.Department of SurgeryOkazaki City HospitalOkazakiJapan
  9. 9.Department of SurgeryTosei General HospitalSetoJapan
  10. 10.Biostatistics Center, Graduate School of MedicineKurume UniversityKurumeJapan

Personalised recommendations